MediPharm Labs Corp. (LABS) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Medipharm Labs Corp..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.267 -- 00:00:04.769 Thank you for standing by and welcome to the MediPharm Labs conference call to discuss 00:00:04.769 -- 00:00:08.350 the company's 26 Q2 results. 00:00:08.350 -- 00:00:14.692 Our speaker on today's call is Greg Hunter, Interim CEO and Chief Financial Officer. 00:00:14.692 -- 00:00:20.414 As a reminder, all participants are in listen-only mode and the conference is being recorded. 00:00:20.414 -- 00:00:24.255 After management's presentation, we will take written questions through the Q&A feature 00:00:24.255 -- 00:00:26.415 on the webcast. 00:00:26.936 -- 00:00:31.080 The information during this call should be considered together with the more detailed 00:00:31.080 -- 00:00:36.082 information, disclosure, financial data, and statements available on the company's 00:00:36.082 -- 00:00:41.223 website and on its CDAR profile at cdarplus.ca. 00:00:41.524 -- 00:00:47.587 As set out on the webcast slide, I would like to note that remarks during this call 00:00:47.587 -- 00:00:50.368 may contain forward-looking information 00:00:50.368 -- 00:00:55.650 and forward-looking statements within the meanings of applicable securities laws. 00:00:55.650 -- 00:01:01.018 This includes, without limitation, statements about many pharma labs, and its current 00:01:01.018 -- 00:01:06.321 and future plans, expectations, intentions, results, operations, levels 00:01:06.321 -- 00:01:10.263 of activity, performance, goals or achievements 00:01:10.263 -- 00:01:15.986 and other future events, trends, profitability, business growth or developments. 00:01:15.986 -- 00:01:20.909 All statements other than statements of historical fact are forward-looking statements. 00:01:20.909 -- 00:01:24.631 The statements made are based on the company's current expectations, 00...